C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration
about
Elevated C-reactive protein levels and ARMS2/HTRA1 gene variants in subjects without age-related macular degeneration.Flicker-induced retinal vasodilatation is not dependent on complement factor H polymorphism in healthy young subjectsAge-related macular degeneration: insights into inflammatory genes.The ARMS2 A69S variant and bilateral advanced age-related macular degenerationComplement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.Gene-gene interaction of CFH, ARMS2, and ARMS2/HTRA1 on the risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese populationCFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study.Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration.Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics.Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study.Complement dysregulation in AMD: RPE-Bruch's membrane-choroidComplement factor H binding of monomeric C-reactive protein downregulates proinflammatory activity and is impaired with at risk polymorphic CFH variantsGenetic predictors of response to photodynamictherapy.Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration.Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment.Risk factors and biomarkers of age-related macular degeneration.Structural and molecular changes in the aging choroid: implications for age-related macular degeneration.THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.Risk factors for exudative age-related macular degeneration in a large French case-control study.Monomeric C-reactive protein and inflammation in age-related macular degeneration.Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study.Alveolar bone loss associated with age-related macular degeneration in males.Macular Degeneration Epidemiology: Nature-Nurture, Lifestyle Factors, Genetic Risk, and Gene-Environment Interactions - The Weisenfeld Award Lecture.C-Reactive Protein As a Mediator of Complement Activation and Inflammatory Signaling in Age-Related Macular Degeneration.C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.Novel Association of High C-Reactive Protein Levels and A69S at Risk Alleles in Wet Age-Related Macular Degeneration Women
P2860
Q34452910-27EE5A04-F47D-4E5D-8432-5568898B07F7Q34477472-51EC5738-DCD4-4867-9892-772E1328B0EAQ34588628-B317E03E-59B6-4D88-B0D1-4A3BC3F90BE1Q34722622-9CED1B19-3E4C-4963-A430-CEF257AB4AD6Q35118257-28D232EC-87D2-41B3-B525-196496527F7FQ35577431-8CDF67F8-43AE-4404-B561-AE04573A26B7Q35679791-F59AF404-F3E8-465F-8300-87BCD8C3377DQ36003675-87D4CB1D-36B4-43CC-942D-9E83675811A7Q36084168-9489E47F-06D0-4E4A-A15B-3AD7449168E0Q36223020-D925D739-879A-4EAC-8DDE-9C17E94ADD72Q36456926-F2AF5E29-B872-4478-AE50-6D52E1F13DDDQ36670874-524839C4-0357-4C4D-A950-CE4A1585FECCQ37931236-15CBE454-E6D6-4387-8CD9-7E3A86A99BCEQ38030051-D44CC9B2-97D7-4F66-A17A-10BED39E5A94Q38192127-024BE7FD-3847-41F8-BEE4-D9DCB02A0B63Q38828895-B941D11E-DE4C-4965-80C5-E1C5779079D5Q38975097-A428688C-7032-4AB0-B098-004A074D3A04Q39024579-EC2995B0-2829-4B85-A4E4-64A5489DEB49Q39624600-2C957A91-E377-4749-92C2-67BA9A089F50Q39633569-F1CEEBC1-03EB-4C99-BE6A-561DE80076ECQ42293425-6E701C94-B1F7-40B9-88BA-EE9DC15C7806Q45799508-4E6C4E54-E547-4F4C-A19E-A9969F4D5BC9Q47149024-190B495D-676C-4D2F-B424-2A3E037F6426Q51758276-156F14E1-8C47-4302-A016-1B58C22D6166Q54957842-30D17C78-A9BD-4B8F-8B68-473BF1BA501CQ58781252-5163DD00-0B61-4B91-88C7-A42D5C1EA7A8
P2860
C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
C-reactive protein and CFH, AR ...... h risk of macular degeneration
@en
C-reactive protein and CFH, AR ...... risk of macular degeneration.
@nl
type
label
C-reactive protein and CFH, AR ...... h risk of macular degeneration
@en
C-reactive protein and CFH, AR ...... risk of macular degeneration.
@nl
prefLabel
C-reactive protein and CFH, AR ...... h risk of macular degeneration
@en
C-reactive protein and CFH, AR ...... risk of macular degeneration.
@nl
P2093
P2860
P1433
P1476
C-reactive protein and CFH, AR ...... h risk of macular degeneration
@en
P2093
Bernard Rosner
Gary Gensler
Johanna M Seddon
P2860
P304
P356
10.1016/J.OPHTHA.2009.11.020
P577
2010-03-26T00:00:00Z